Stabilised IL-21 compositions

Details for Australian Patent Application No. 2006256802 (hide)

Owner Novo Nordisk A/S

Inventors Persson, Malin; Bukrinsky, Jens Thostrup

Agent Shelston IP

Pub. Number AU-A-2006256802

PCT Pub. Number WO2006/131515

Priority 05104887.4 06.06.05 EP

Filing date 6 June 2006

Wipo publication date 14 December 2006

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/131515 Priority application(s): WO2006/131515

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006256814-Microwave platform for generating marks on food products and method of using same

2006256791-Polypeptides having antimicrobial activity and polynucleotides encoding same